- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Alembic Pharma's US unit reported its first prescription sale of Pivya®, an antibiotic for UTIs. This marks a strategic entry into the US branded pharmaceutical market, establishing a specialty portfolio for the company.